Popular
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual EventPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CETranslating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
MinuteCE®Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Safety in oHCM Therapy: How and When to Transition Treatment?
MinuteCE®Safety in oHCM Therapy: How and When to Transition Treatment?
Not All VMAT2s Are the Same: Understanding the PK/PD Differences
MinuteCE®Not All VMAT2s Are the Same: Understanding the PK/PD Differences
CME/CE
- ADC Learning Center
- Advances in Chronic Kidney Disease
- Allergy, Asthma, and Immunology
- Amyloid Transthyretin (ATTR) Learning Center
- Bladder Health/Incontinence
- Breast Cancer and Breast Health
- Cardiology
- Clinical Pharmacology
- Colorectal Cancer
- Critical Care
- Dermatology
- Diabetes
- Diabetes and Endocrinology
- Emergency Medicine
- Endocrinology
- Endometriosis
- Gastroenterology and Hepatology
- General Medicine and Primary Care
- Genetics
- Geriatrics
- Gynecologic Cancers
- Hospital Medicine
- IBS
- Infectious Diseases
- Medical Device and Technology CME
- Mental Health
- Nephrology
- Neurology and Neurosurgery
- Nutrition
- Obesity
- Obstetrics
- Obstetrics and Gynecology
- Oncology and Hematology
- Ophthalmology
- Osteoporosis
- Pathology and Laboratory Medicine
- Pediatrics
- Psychiatry and Mental Health
- Public Health
- Pulmonary Medicine
- Radiology
- Rare and Orphan Diseases
- Reproductive Endocrinology & Infertility
- Rheumatology
- Sleep Disorders
- Sleep Medicine
- Surgery
- Transplantation
- Urology
- Vascular Medicine
- Women's Health
- AXIS Medical Education
- Clinician’s Roundtable CME
- DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)
- DataPulse: Key Clinical Trial Insights in Non-Muscle Invasive Bladder Cancer (NMIBC) From AUA 2025
- DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
- Fetal Fibronectin (fFN) and Preterm Labor
- GI Insights CME
- Global Liver Academy
- Global Neurology Academy
- Global Oncology Academy
- Global Women's Health Academy
- Grand Rounds Nation CME
- Medtelligence
- MinuteCE®
- Multidisciplinary Management of Extrahepatic Organ Failures in Patients with Advanced Liver Disease
- Neuro Frontiers CME
- Omnia Education
- PACE-CME
- Project Oncology® CME
- Prova Education
- RMEI
- Switching Gears in Retinal Disease: Real-World Expectations for Second-Generation Therapies
- TotalCME
- Bridging the Gap in FSGS: From Interpreting Proteinuria to Emerging Therapies for Enhancing Patient Outcomes and Quality of Life
- Transforming Care in C3G and IC-MPGN: Advancing Diagnosis, Disease Monitoring & Targeted Complement Therapy Across the Patient Journey



































































